Rie Kubota
Research Subjects
Rie Kubota has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Takako Komiyama
Kitasato University, Tokyo, Japan
5 shared publicationsSatoshi Tsunematsu
Research Center for Liver Diseases
2 shared publicationsAya Tsukamoto
Kitasato University, Tokyo, Japan
1 shared publicationAyuko Okamoto
Kitasato University, Tokyo, Japan
1 shared publicationEmi Sezaki
北里大学薬学部臨床薬学研究・教育センター臨床薬学教育部
1 shared publicationFumihiko Kaneko
Research Center for Liver Diseases
1 shared publication
Latest Publications
- Open Access
- 10 June 2023
- Published by The Japan Primary Care Association in An Official Journal of the Japan Primary Care Association
- Vol. 46 (2) , 43-51
Webアンケートを活用した緊急避妊薬に対する薬剤師の意識に関する横断的研究
目的:緊急避妊薬(ECP)のオンライン診療では,研修を受けた薬剤師が調剤,服薬指導を行う.またECPのover-the-counter(OTC)化についても検討されている.本研究は薬剤師のECPへの意識や取り組み現状を明らかにする. 方法:無作為に選択された薬局薬剤師229名を対象に,Webアンケート調査を実施した. 結果:薬剤師のECP関連知識の自己評価は作用機序の知識不足31.9%をはじめ低く,薬剤師の60.3%は女性の心理面サポートに不安があることが示唆された.オンライン診療によるECP処方箋を応需した薬剤師はいなかった.46.9%が将来研修を受講し処方箋を応需したいと考えていた.44.5%の薬剤師は,ECPのOTC化に反対だった. 結論:多くの薬剤師はECPの知識不足,患者の心理的サポートに不安を感じている.対応マニュアルや説明書,OTC化への準備も必要であると考えられた.
- 10 June 2023
- Published by The Japan Primary Care Association in An Official Journal of the Japan Primary Care Association
- Vol. 46 (2) , 43-51
Open AccessWebアンケートを活用した緊急避妊薬に対する薬剤師の意識に関する横断的研究
目的:緊急避妊薬(ECP)のオンライン診療では,研修を受けた薬剤師が調剤,服薬指導を行う.またECPのover-the-counter(OTC)化についても検討されている.本研究は薬剤師のECPへの意識や取り組み現状を明らかにする. 方法:無作為に選択された薬局薬剤師229名を対象に,Webアンケート調査を実施した. 結果:薬剤師のECP関連知識の自己評価は作用機序の知識不足31.9%をはじめ低く,薬剤師の60.3%は女性の心理面サポートに不安があることが示唆された.オンライン診療によるECP処方箋を応需した薬剤師はいなかった.46.9%が将来研修を受講し処方箋を応需したいと考えていた.44.5%の薬剤師は,ECPのOTC化に反対だった. 結論:多くの薬剤師はECPの知識不足,患者の心理的サポートに不安を感じている.対応マニュアルや説明書,OTC化への準備も必要であると考えられた.
- Open Access
Evaluation of a New Home Patient Services Practicum for Community Pharmacy Students in Japan
This study aimed to evaluate the usefulness of the practicum as well as assess the knowledge, skills, and various specific realizations that the students gained from it. A total of 244 students role-played a scenario in which a pharmacist visited a patient at home and provided pharmaceutical management services. After completing the practicum, the students completed (i) a questionnaire survey consisting of six questions that assessed their level of understanding of the role of pharmacists in home medical care and (ii) a rubric survey that evaluated their learning achievement. In addition, they submitted practicum portfolios describing the patients’ living conditions, physical conditions, and background as well as the services that required consideration of said variables. Their responses to the portfolio item “What were noticed through the practicum” were analyzed using the grounded theory approach. After the practicum, 45% and 53% of the students reported having a full and partial understanding of a pharmacists’ role in home medical care. The students’ mean ± standard deviation rubric score was 3.0 ± 0.4. They classified monitoring drug use, support for improving medication adherence, and observation to identify side effects early as major service categories in home medical care. The practicum led the students to perceive the need for communication with patients and various healthcare professionals to improve their readiness for practical training.
Open AccessEvaluation of a New Home Patient Services Practicum for Community Pharmacy Students in Japan
This study aimed to evaluate the usefulness of the practicum as well as assess the knowledge, skills, and various specific realizations that the students gained from it. A total of 244 students role-played a scenario in which a pharmacist visited a patient at home and provided pharmaceutical management services. After completing the practicum, the students completed (i) a questionnaire survey consisting of six questions that assessed their level of understanding of the role of pharmacists in home medical care and (ii) a rubric survey that evaluated their learning achievement. In addition, they submitted practicum portfolios describing the patients’ living conditions, physical conditions, and background as well as the services that required consideration of said variables. Their responses to the portfolio item “What were noticed through the practicum” were analyzed using the grounded theory approach. After the practicum, 45% and 53% of the students reported having a full and partial understanding of a pharmacists’ role in home medical care. The students’ mean ± standard deviation rubric score was 3.0 ± 0.4. They classified monitoring drug use, support for improving medication adherence, and observation to identify side effects early as major service categories in home medical care. The practicum led the students to perceive the need for communication with patients and various healthcare professionals to improve their readiness for practical training.
- Open Access
Clinical Pharmacy Education in Japan: Using Simulated Patients in Laboratory-Based Communication-Skills Training before Clinical Practice
The Japanese pharmaceutical curriculum was extended from four to six years in 2006. Students now receive practical communication-skills training in their fourth year, before progressing to train in hospital and community pharmacies in their fifth year. Kitasato University School of Pharmacy, Tokyo, had established a program to meet these aims before the 2006 guidance. In the present study, we discuss and evaluate the features of this communication-skills training program. This study enrolled 242 fourth-year pharmacy students at Kitasato University. Students filled out a questionnaire survey after completing the laboratory element of their undergraduate education. As part of training, students were asked to obtain patient data from a model medical chart, before performing simulated patient interviews covering hospital admission and patient counseling. These simulations were repeated in a small group, and feedback was provided to students by both the simulated patient and the faculty after each presentation. It was found that students were able to develop their communication skills through this approach. Thus, an effective system of gradual and continuous training has been developed, which allows students to acquire clinical and practical communication skills.
Open AccessClinical Pharmacy Education in Japan: Using Simulated Patients in Laboratory-Based Communication-Skills Training before Clinical Practice
The Japanese pharmaceutical curriculum was extended from four to six years in 2006. Students now receive practical communication-skills training in their fourth year, before progressing to train in hospital and community pharmacies in their fifth year. Kitasato University School of Pharmacy, Tokyo, had established a program to meet these aims before the 2006 guidance. In the present study, we discuss and evaluate the features of this communication-skills training program. This study enrolled 242 fourth-year pharmacy students at Kitasato University. Students filled out a questionnaire survey after completing the laboratory element of their undergraduate education. As part of training, students were asked to obtain patient data from a model medical chart, before performing simulated patient interviews covering hospital admission and patient counseling. These simulations were repeated in a small group, and feedback was provided to students by both the simulated patient and the faculty after each presentation. It was found that students were able to develop their communication skills through this approach. Thus, an effective system of gradual and continuous training has been developed, which allows students to acquire clinical and practical communication skills.
- Open Access
- 1 January 2018
- Published by Knowledge Enterprise Journals in Medical Research Archives
- Vol. 6 (4)
The Development of Transdermal Ketamine Patch
Objective We prepared the transdermal ketamine patch, determined the size of the patch to yield proper plasma ketamine level due to human skin permeability and the amount of residual ketamine in the patch, and estimated the utility of this ketamine transdermal patch when it will be applied to patients. Methods A ketamine patch was prepared with ketamine hydrochloride intramuscular solution (3.0mg/cm2). The ketamine patch was put on the skin samples taken from the human. The solutions of the diffusion cell were examined every two hours after the application until 30 hours. The amount of ketamine that has penetrated into the skin was measured by using HPLC system, and Flux of transdermal ketamine patch was defined. Results The cumulative ketamine permeation amount was found to be 785.6 mg/cm2 at the 30-hour sampling, showing a stable Flux of 30.1 mg/cm2/hr during the period from 10 to 30 hours of sampling. Conclusion We have been attempting to formulate transdermal ketamine patches at a size of 155 cm2 to yield a plasma ketamine level of 50 ng/mL for use in the clinical practice setting. The patch may become a formulation of choice as an analgesic adjuvant for combined use with opioids.
- 1 January 2018
- Published by Knowledge Enterprise Journals in Medical Research Archives
- Vol. 6 (4)
Open AccessThe Development of Transdermal Ketamine Patch
Objective We prepared the transdermal ketamine patch, determined the size of the patch to yield proper plasma ketamine level due to human skin permeability and the amount of residual ketamine in the patch, and estimated the utility of this ketamine transdermal patch when it will be applied to patients. Methods A ketamine patch was prepared with ketamine hydrochloride intramuscular solution (3.0mg/cm2). The ketamine patch was put on the skin samples taken from the human. The solutions of the diffusion cell were examined every two hours after the application until 30 hours. The amount of ketamine that has penetrated into the skin was measured by using HPLC system, and Flux of transdermal ketamine patch was defined. Results The cumulative ketamine permeation amount was found to be 785.6 mg/cm2 at the 30-hour sampling, showing a stable Flux of 30.1 mg/cm2/hr during the period from 10 to 30 hours of sampling. Conclusion We have been attempting to formulate transdermal ketamine patches at a size of 155 cm2 to yield a plasma ketamine level of 50 ng/mL for use in the clinical practice setting. The patch may become a formulation of choice as an analgesic adjuvant for combined use with opioids.
- Open Access
- 8 September 2010
- Published by Hindawi Limited in Hepatitis Research and Treatment
- Vol. 2010, 1-5
Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection
Aims. To determine whether the erythrocyte phosphorylated ribavirin (RBV) level might be a useful index of EVR and risk of anemia and to determine the optimal dose of RBV in 24 patients with hepatitis C with pegylated interferon and RBV. Methodology. The RBV level was measured by a high-performance liquid chromatography. Results and Conclusion. In patients aged 50 years or over, a negative correlation (, ) was observed between the RBV level at week 2 and rate of Hb reduction () at week 4. The at week 4 was significantly greater in patients with RBV levels of ≥800 ( %) than in patients with RBV levels <800 ( %). None of the patients with RBV levels <600 at week 2 achieved EVR and SVR. Thus the optimal levels of erythrocyte phosphorylated RBV at week 2 of therapy in order to achieve EVR without anemia seemed to be 600–800 .
- 8 September 2010
- Published by Hindawi Limited in Hepatitis Research and Treatment
- Vol. 2010, 1-5
Open AccessOptimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection
Aims. To determine whether the erythrocyte phosphorylated ribavirin (RBV) level might be a useful index of EVR and risk of anemia and to determine the optimal dose of RBV in 24 patients with hepatitis C with pegylated interferon and RBV. Methodology. The RBV level was measured by a high-performance liquid chromatography. Results and Conclusion. In patients aged 50 years or over, a negative correlation (, ) was observed between the RBV level at week 2 and rate of Hb reduction () at week 4. The at week 4 was significantly greater in patients with RBV levels of ≥800 ( %) than in patients with RBV levels <800 ( %). None of the patients with RBV levels <600 at week 2 achieved EVR and SVR. Thus the optimal levels of erythrocyte phosphorylated RBV at week 2 of therapy in order to achieve EVR without anemia seemed to be 600–800 .
- 29 February 2008
- Published by Elsevier in Current Therapeutic Research
- Vol. 69 (1) , 49-55
Pharmacokinetics and postoperative analgesia of epidural tramadol: A prospective, pilot study
- 29 February 2008
- Published by Elsevier in Current Therapeutic Research
- Vol. 69 (1) , 49-55
Pharmacokinetics and postoperative analgesia of epidural tramadol: A prospective, pilot study
- 1 September 2007
- Vol. 54 (78) , 1752-7
Clinical application of the leukocyte migration test and new diagnostic criteria for identifying causative agents in patients with drug-induced liver injury.
We examined the usefulness of the leukocyte migration test (LMT) in the identification of agents causing drug-induced liver injury (DILI). In 14 patients who were tentatively diagnosed as having DILI in Kitasato Institute Hospital, pharmacists collected and evaluated drug information and patients' medication histories to identify causative agents. Simultaneously, LMT and drug lymphocyte stimulation test (DLST) were performed. Furthermore, scoring was performed according to the diagnostic criteria established by the International Consensus Meeting (ICM) and the Digestive Disease Week-Japan 2004 (DDW-J). LMT-positive agents showed a higher ICM score compared to DLST-positive agents. The rate of LMT-positive agents was examined with respect to ICM assessment, and 0%, 25%, 33%, and 100% of agents regarded as unrelated/unlikely, possible, probable, and highly probable showed positive reactions on LMT, respectively; the rate of LMT-positive agents increased with the degree of the agent's involvement. When the results of LMT were applied to the DDW-J criteria, there was a correlation with the ICM criteria in comparison to scoring based on the results of DLST. LMT may be useful for identifying agents causing DILI. Furthermore, the collection and evaluation of drug and patient information and in vitro testing in the identification of causative agents may support more reliable diagnosis.
- 1 September 2007
- Vol. 54 (78) , 1752-7
Clinical application of the leukocyte migration test and new diagnostic criteria for identifying causative agents in patients with drug-induced liver injury.
We examined the usefulness of the leukocyte migration test (LMT) in the identification of agents causing drug-induced liver injury (DILI). In 14 patients who were tentatively diagnosed as having DILI in Kitasato Institute Hospital, pharmacists collected and evaluated drug information and patients' medication histories to identify causative agents. Simultaneously, LMT and drug lymphocyte stimulation test (DLST) were performed. Furthermore, scoring was performed according to the diagnostic criteria established by the International Consensus Meeting (ICM) and the Digestive Disease Week-Japan 2004 (DDW-J). LMT-positive agents showed a higher ICM score compared to DLST-positive agents. The rate of LMT-positive agents was examined with respect to ICM assessment, and 0%, 25%, 33%, and 100% of agents regarded as unrelated/unlikely, possible, probable, and highly probable showed positive reactions on LMT, respectively; the rate of LMT-positive agents increased with the degree of the agent's involvement. When the results of LMT were applied to the DDW-J criteria, there was a correlation with the ICM criteria in comparison to scoring based on the results of DLST. LMT may be useful for identifying agents causing DILI. Furthermore, the collection and evaluation of drug and patient information and in vitro testing in the identification of causative agents may support more reliable diagnosis.
- 1 January 2001
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 121 (5) , 355-364
Evaluation of the Method for Nifedipine Administration for a Rapid Onset of Clinical Effect: A Clinical Study in Normal Volunteers.
Nifedipine is frequently used for patients who require an immediate reduction of blood pressure elevated temporarily by various administration techniques including sublingual route without administrating intravenous infusion of vasodilator. A cross-over clinical study was conducted to investigate the optimal administration method of nifedipine for rapid management of hypertension. Four method of administering 10 mg nifedipine (the capsule was bitten and swallowed, sublingually with a hole in it or the contents administered orally or intranasally with a syringe) were evaluated with regarded efficacy, safety, and usefulness in 6 normal volunteers. Systolic and diastolic blood pressures were correlated with the nifedipine serum concentration in each method. Nifedipine pharmacokinetic parameters differed among the 4 administration methods. Nifedipine was absorbed rapidly by not only intestinal mucosa but also the nasal or oral mucosa. The pharmacological effect of intranasal or sublingual administration was superior. However, mint oil which is present in nifedipine capsules stimulates nasal mucosa when administered intranasally. For clinical usage, nifedipine capsules in which a hole is made with a needle, administered sublingually, can be effectively and safely used for rapid management of systemic hypertension.
- 1 January 2001
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 121 (5) , 355-364
Evaluation of the Method for Nifedipine Administration for a Rapid Onset of Clinical Effect: A Clinical Study in Normal Volunteers.
Nifedipine is frequently used for patients who require an immediate reduction of blood pressure elevated temporarily by various administration techniques including sublingual route without administrating intravenous infusion of vasodilator. A cross-over clinical study was conducted to investigate the optimal administration method of nifedipine for rapid management of hypertension. Four method of administering 10 mg nifedipine (the capsule was bitten and swallowed, sublingually with a hole in it or the contents administered orally or intranasally with a syringe) were evaluated with regarded efficacy, safety, and usefulness in 6 normal volunteers. Systolic and diastolic blood pressures were correlated with the nifedipine serum concentration in each method. Nifedipine pharmacokinetic parameters differed among the 4 administration methods. Nifedipine was absorbed rapidly by not only intestinal mucosa but also the nasal or oral mucosa. The pharmacological effect of intranasal or sublingual administration was superior. However, mint oil which is present in nifedipine capsules stimulates nasal mucosa when administered intranasally. For clinical usage, nifedipine capsules in which a hole is made with a needle, administered sublingually, can be effectively and safely used for rapid management of systemic hypertension.